Epsilon Healthcare's total inventories for the quarter that ended in Dec. 2025 was A$1.20 Mil. Epsilon Healthcare's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was A$0.83 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Epsilon Healthcare's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was A$-0.04.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Epsilon Healthcare's Days Inventory for the
six
months ended in Dec. 2025 was 81.63.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Epsilon Healthcare's Inventory Turnover for the quarter that ended in Dec. 2025 was 2.24.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Epsilon Healthcare's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.14.
Epsilon Healthcare (ASX:EPN) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Epsilon Healthcare's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Epsilon Healthcare's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Epsilon Healthcare Total Inventories Related Terms
Epsilon Healthcare Total Inventories Historical Data
* Premium members only.
The historical data trend for Epsilon Healthcare's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Epsilon Healthcare (ASX:EPN) has a Total Inventories of A$1.20 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Epsilon Healthcare and its competitors.
Is Epsilon Healthcare's Total Inventories too high?
Epsilon Healthcare's current Total Inventories is A$1.20 Mil.
How does Epsilon Healthcare's Total Inventories compare to ZTS?
Epsilon Healthcare's Total Inventories of A$1.20 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Epsilon Healthcare and its competitors. Epsilon Healthcare's current Total Inventories is A$1.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epsilon Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Epsilon Healthcare (ASX:EPN) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 26.7% below its estimated fair value. The current Total Inventories is A$1.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Epsilon Healthcare (ASX:EPN), the current Total Inventories is A$1.20 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Epsilon Healthcare Ltd is an Australian based, globally active healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation & pharmacy services. The company offers end-to-end solutions across the healthcare spectrum: from product development and manufacturing to patient care. The company's three (3) main operating segments are: a. Contract Development and Manufacturing activities, b. Telehealth medical practice services; and c. Pharmacy services. The majority of revenue is derived from the Contract Development and Manufacturing activities segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EPN has been successfully added to your 